Skip to content

Clinical efficacy of oblique anterior lumbar interbody fusion (OLIF) for lumbar degenerative disease

Clinical efficacy of oblique anterior lumbar interbody fusion (OLIF) for lumbar degenerative disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021363
Enrollment
Unknown
Registered
2019-02-17
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar degenerative disease

Interventions

Group 1:OLIF surgery(standalone/combined fixation)
Group 2:PLIF/TLIF surgery

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Degenerative lumbar spondylolisthesis or spondylolysis (I or II°); 2. Degenerative lumbar spinal stenosis; 3. Lumbar spine instability; 4. Lumbar degenerative disk disease; 5. Adjacent segment disease; 6. Conservative treatment is invalid over 3 months; 7. Patients signed informed consent before surgery; 8. Patients have the ability to act autonomously.

Exclusion criteria

Exclusion criteria: 1. Over II degrees lumbar spondylolisthesis or spondylolysis; 2. Lumbar trauma, infection, tumor, simple lumbar disc herniation, severe osteoporosis and lumbar deformity; 3. History of left abdominal surgery within 1 year; 4. Morbid obesity; 5. Serious medical diseases, such as heart, lung, liver, kidney and other important organ dysfunction and severe immune diseases; 6. People with mental disorders and non-compliant.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Oswestry Disability Index;fusion rate;cage subsidence;duration of operation;intraoperative blood loss;complication;

Secondary

MeasureTime frame
lumbar lordosis angle;ntervertebral foramen area;intervertebral foramen height;intervertebral disc height;

Countries

China

Contacts

Public ContactJiang Xiaobing

First Affiliated Hospital of Guangzhou University of Chinese Medicine

spinedrjxb@sina.com+86 18218181403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026